{"DataElement":{"publicId":"3113330","version":"1","preferredName":"Soft Tissue Sarcoma Necrosis Score","preferredDefinition":"Numeric value to represent the amount of dying tissue (necrosis) present in a sample of tumor.","longName":"SAR_NECR_SC","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3113323","version":"1","preferredName":"Soft Tissue Sarcoma Necrosis","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones._The pathologic localized death of living cells, as from infection or interruption of the blood supply, generally associated with severe cellular trauma caused by progressive degradation by enzymes. Characterized by mitochondrial swelling, nuclear flocculation, and uncontrolled cell lysis, it is unprogrammed death of living tissue and cells.","longName":"SAR_NECR","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2963681","version":"1","preferredName":"Soft Tissue Sarcoma","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","longName":"C9306","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"79667DFC-075B-3EB9-E040-BB89AD43658B","latestVersionIndicator":"Yes","beginDate":"2009-11-27","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-27","modifiedBy":"ONEDATA","dateModified":"2009-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2448417","version":"1","preferredName":"Necrosis","preferredDefinition":"Necrosis; the localized death of living cells as from infection or the interruption of blood supply; unprogrammed death of living tissue.","longName":"C16897","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Necrotic Process","conceptCode":"C16897","definition":"A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C236CBF-CD55-2FB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-06","modifiedBy":"ONEDATA","dateModified":"2006-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899E37C2-2716-0989-E040-BB89AD432585","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3113325","version":"1","preferredName":"Soft Tissue Sarcoma Necrosis Score","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones._The pathologic localized death of living cells, as from infection or interruption of the blood supply, generally associated with severe cellular trauma caused by progressive degradation by enzymes. Characterized by mitochondrial swelling, nuclear flocculation, and uncontrolled cell lysis, it is unprogrammed death of living tissue and cells._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"SAR_NECR_SC","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"2","valueDescription":"Tumor necrosis score of 2","ValueMeaning":{"publicId":"3113326","version":"1","preferredName":"Tumor necrosis score of 2","longName":"3113326","preferredDefinition":"Tumor necrosis score of 2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899E37C2-2750-0989-E040-BB89AD432585","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899E37C2-2769-0989-E040-BB89AD432585","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"ONEDATA","dateModified":"2010-06-22","deletedIndicator":"No"},{"value":"1","valueDescription":"Tumor necrosis score of 1","ValueMeaning":{"publicId":"3113327","version":"1","preferredName":"Tumor necrosis score of 1","longName":"3113327","preferredDefinition":"Tumor necrosis score of 1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899E37C2-2773-0989-E040-BB89AD432585","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899E37C2-278C-0989-E040-BB89AD432585","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"ONEDATA","dateModified":"2010-06-22","deletedIndicator":"No"},{"value":"0","valueDescription":"Tumor necrosis score of 0","ValueMeaning":{"publicId":"3113328","version":"1","preferredName":"Tumor necrosis score of 0","longName":"3113328","preferredDefinition":"Tumor necrosis score of 0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899E37C2-2796-0989-E040-BB89AD432585","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899E37C2-27AF-0989-E040-BB89AD432585","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"ONEDATA","dateModified":"2010-06-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3113324","version":"1","preferredName":"Soft Tissue Sarcoma Necrosis Score","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.:The pathologic localized death of living cells, as from infection or interruption of the blood supply, generally associated with severe cellular trauma caused by progressive degradation by enzymes. Characterized by mitochondrial swelling, nuclear flocculation, and uncontrolled cell lysis, it is unprogrammed death of living tissue and cells.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C9306:C16897:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Necrotic Process","conceptCode":"C16897","definition":"A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899E37C2-272B-0989-E040-BB89AD432585","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"ONEDATA","dateModified":"2010-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899E37C2-273C-0989-E040-BB89AD432585","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"ONEDATA","dateModified":"2010-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812731","version":"1","longName":"U Washington","context":"NCIP"},{"publicId":"2812734","version":"1","longName":"U Washington New CDEs","context":"NCIP"},{"publicId":"3113297","version":"1","longName":"FMISO Soft Tissue Sarcoma Study","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor Necrosis","type":"Preferred Question Text","description":"Tumor Necrosis","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899E37C2-27B9-0989-E040-BB89AD432585","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"Curated for UWMC Sarcoma Trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}